PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.
Yu Jo Chua
No relevant relationships to disclose
Christos Stelios Karapetis
No relevant relationships to disclose
Craig Underhill
No relevant relationships to disclose
Louise M. Nott
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Michelle F. Cronk
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose
Nicole Wong
No relevant relationships to disclose
Katrin Marie Sjoquist
No relevant relationships to disclose
Andrew Victor Biankin
No relevant relationships to disclose